- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04487782
Pragmatic Weight Loss Intervention During Menopause (WISE)
Study Overview
Status
Conditions
Intervention / Treatment
Detailed Description
This is a participatory research study which will enroll women (n of up to 56) with experience of menopause to help identify preferred strategies (modalities) for weight loss, which will combine calorie (dietary) restriction and exercise tactics.
Aim 1: Explore attitudes and perceptions about weight gain during the menopause transition, and identify weight loss strategies from the patient (peer) perspective.
- The investigators will apply these learnings: 1) to understand barriers for weight management during menopause; 2) to establish strategies to guide retention; 3) to finalize the intervention structure, including feedback on the frequency and duration of the study visits; and 4) to gather feedback on menopause-specific education resources set to be provided throughout the intervention.
Aim 2: Engage the Community Advisory Board (CAB) of the Louisiana Clinical and Translational Center (LA CaTS) to understand scalability and community-based implementation of an intervention tailored for women in perimenopause.
- The investigators will then utilize the Louisiana Clinical & Translational Science Center (LA CaTS) Community Advisory Board (CAB) to help us tailor a lifestyle intervention in perimenopausal women with emphasis on scalability and community-based implementation using learnings obtained from the focus groups.
Study Type
Enrollment (Actual)
Contacts and Locations
Study Locations
-
-
Louisiana
-
Baton Rouge, Louisiana, United States, 70808
- Pennington Biomedical Research Center
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Age 45 to 60 years
- Currently experiencing (or have experienced) the one of the following menopause-related traits:
- Vasomotor symptoms including hot flashes and/or night sweats
- Irregular menstrual cycle
- African-American (Black) or Caucasian (White) race
- Self-report having a desire to lose (or maintain) weight during menopause
- Willing to be recorded during the focus group for transcription purposes
Exclusion Criteria:
- Are pre-menopausal
- Non-English speaking
Study Plan
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Cross-Sectional
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
High SES / African-American Women
Semi-structured focus groups of 6 to 8 women per group will be conducted.
Women in these groups will be of higher socioeconomic status (SES) and will be African-American/Black.
|
The investigators are enrolling up to 56 women (total) to participate in semi-structured focus groups of 6-8 women per group conducted either in-person or virtually (online) to help us tailor a lifestyle intervention for midlife women during perimenopause.
|
|
High SES / Caucasian Women
Semi-structured focus groups of 6 to 8 women per group will be conducted.
Women in these groups will be of higher socioeconomic status (SES) and will be Caucasian/White.
|
The investigators are enrolling up to 56 women (total) to participate in semi-structured focus groups of 6-8 women per group conducted either in-person or virtually (online) to help us tailor a lifestyle intervention for midlife women during perimenopause.
|
|
Low SES / African-American Women
Semi-structured focus groups of 6 to 8 women per group will be conducted.
Women in these groups will be of lower socioeconomic status (SES) and will be African-American/Black.
|
The investigators are enrolling up to 56 women (total) to participate in semi-structured focus groups of 6-8 women per group conducted either in-person or virtually (online) to help us tailor a lifestyle intervention for midlife women during perimenopause.
|
|
Low SES / Caucasian Women
Semi-structured focus groups of 6 to 8 women per group will be conducted.
Women in these groups will be of lower socioeconomic status (SES) and will be Caucasian/White.
|
The investigators are enrolling up to 56 women (total) to participate in semi-structured focus groups of 6-8 women per group conducted either in-person or virtually (online) to help us tailor a lifestyle intervention for midlife women during perimenopause.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Duration
Time Frame: 1 day
|
Identify how long would women prefer the intervention to last (e.g., number of months).
|
1 day
|
|
Motivation
Time Frame: 1 day
|
Identify what motivates women (e.g., group setting, incentives, etc.).
|
1 day
|
|
Time Commitment
Time Frame: 1 day
|
Identify how many times (e.g., days per week) that women would want to participate in a lifestyle intervention.
|
1 day
|
|
Diet
Time Frame: 1 day
|
Identify the types of diets (e.g., keto, Mediterranean, intermittent fasting, etc.) that women have attempted before, and which diets they liked best.
|
1 day
|
|
Exercise
Time Frame: 1 day
|
Identify the types of exercises (e.g., swimming, walking, weight training, etc.) that women like to do or would like to try.
|
1 day
|
|
Location
Time Frame: 1 day
|
Identify where women would want to go to receive a lifestyle intervention (e.g., at Pennington, in local fitness centers, virtual/online, etc.).
|
1 day
|
|
Barriers
Time Frame: 1 day
|
Identify specific barriers that women would encounter if participating in a lifestyle intervention.
|
1 day
|
|
Menopause Education
Time Frame: 1 day
|
Identify specific education topics that women would like to receive as part of their lifestyle intervention.
|
1 day
|
Collaborators and Investigators
Sponsor
Publications and helpful links
Study record dates
Study Major Dates
Study Start (Actual)
Primary Completion (Actual)
Study Completion (Actual)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (Actual)
Study Record Updates
Last Update Posted (Actual)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- PBRC 2019-056
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Menopause
-
Western Norway University of Applied SciencesCompleted
-
Riphah International UniversityCompleted
-
Englewood Hospital and Medical CenterNanohealth, Inc.WithdrawnMenopause SymptomsUnited States
-
Englewood Hospital and Medical CenterNanohealth, Inc.CompletedMenopause SymptomsUnited States
-
University of Colorado, DenverCompletedMenopause | Pre-menopauseUnited States
-
S.LAB (SOLOWAYS)Center of New Medical TechnologiesCompletedMenopause SymptomsRussian Federation
-
Aydin Adnan Menderes UniversityUludag UniversityCompletedMenopause | Menopause Related ConditionsTurkey (Türkiye)
-
BHR Pharma, LLCTerminatedMenopause Related ConditionsGermany
-
Singapore General HospitalRecruitingMenopause | Menopause Related ConditionsSingapore
-
University of ArkansasCompletedMenopause Related ConditionsUnited States
Clinical Trials on Focus Groups
-
Sandra BucciUniversity of Edinburgh; NHS Lothian; Manchester University NHS Foundation Trust and other collaboratorsCompletedChild Sexual Abuse, Confirmed, SequelaUnited Kingdom
-
Greater Manchester Mental Health NHS Foundation...Manchester University NHS Foundation Trust; University of Manchester; Anna Freud... and other collaboratorsCompletedMental Health IssueUnited Kingdom
-
Memorial Sloan Kettering Cancer CenterCompletedBreast Cancer | Colorectal Cancer | Lung CancerUnited States
-
Queen's University, BelfastCompletedAge Related Macular DegenerationUnited Kingdom
-
Gia MuddWest Virginia UniversityCompletedAdverse Childhood ExperiencesUnited States
-
Memorial Sloan Kettering Cancer CenterNational Cancer Institute (NCI); National Institutes of Health (NIH); Virginia...CompletedBreast Cancer | Lung Cancer | Prostate CancerUnited States
-
Assistance Publique - Hôpitaux de ParisInstitut National de la Santé Et de la Recherche Médicale, FranceNot yet recruitingSyringomyelia | Chiari MalformationFrance
-
University of TorontoCompletedBreastfeeding | Vulnerable Population | Breast Pumping | Infant NutritionCanada
-
Bournemouth UniversityDorset County Hospital NHS Foundation TrustCompletedExperience, LifeUnited Kingdom
-
Thomas Jefferson UniversityPatient-Centered Outcomes Research InstituteNot yet recruitingPatient Engagement | Autism Spectrum Disorder